Find out more on how to get involved with AUGS.
The American Urogynecologic Society's PFD Week 2023 is the year’s largest venue for those in the field of urogynecology and Female Pelvic Medicine and Reconstructive Surgery to come together for education and networking.
Present your latest findings and best practices, attend inspiring presentations and interactive workshops, engage in formal and informal dialogue, and establish or reinforce the bonds that will help you achieve the most important work of your career in Portland, Oregon or virtually on October 3-7, 2023!
Call for PFD Week Program Committee Members
Application deadline: November 11, 2022
AUGS is currently seeking volunteers to serve on the PFD Week Program Committee. The following positions are available:
Click here for more information!
November 21—Call for abstract and video reviewers opens
December 30—Abstract and video reviewer submission deadline
January 10—Call for abstracts, workshops, and roundtables opens
February 23—Workshop and roundtable submissions deadline
April 13—Abstract submission deadline
May 23—Registration opens
Urogynecology for the Advanced Practice Provider
Urogyn for the APP is AUGS' one-of-a-kind course specifically designed for nurse practitioners, nurses, physical therapists, and physician assistants to foster a greater understanding of the current evaluation and management options that exist in Urogynecology today and gain valuable insights on practical applications that can be implemented immediately. Join us in Washington, D.C. or virtually on May 11-13, 2023!
The AUGS APP Program Planning Committee is excited to open the Call for Roundtables for the Urogynecology for the Advanced Practice Provider 2023 course. The 2023 Roundtables will, for the first time, feature the option for facilitators to present virtually. Submit your topic today!
Roundtables are intended to be facilitated discussions on a topic of the facilitator’s choosing. The format for the roundtables is up to each facilitator. The role of the facilitator is to share information/perspectives, create talking points and engage attendees in discussions either through case studies or Q&A or both.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More